White Matter Lesion Progression: Genome-Wide Search for Genetic Influences

Background and Purpose— White matter lesion (WML) progression on magnetic resonance imaging is related to cognitive decline and stroke, but its determinants besides baseline WML burden are largely unknown. Here, we estimated heritability of WML progression, and sought common genetic variants associated with WML progression in elderly participants from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium. Methods— Heritability of WML progression was calculated in the Framingham Heart Study. The genome-wide association study included 7773 elderly participants from 10 cohorts. To assess the relative contribution of genetic factors to progression of WML, we compared in 7 cohorts risk models including demographics, vascular risk factors plus single-nucleotide polymorphisms that have been shown to be associated cross-sectionally with WML in the current and previous association studies. Results— A total of 1085 subjects showed WML progression. The heritability estimate for WML progression was low at 6.5%, and no single-nucleotide polymorphisms achieved genome-wide significance (P<5×10−8). Four loci were suggestive (P<1×10−5) of an association with WML progression: 10q24.32 (rs10883817, P=1.46×10−6); 12q13.13 (rs4761974, P=8.71×10−7); 20p12.1 (rs6135309, P=3.69×10−6); and 4p15.31 (rs7664442, P=2.26×10−6). Variants that have been previously related to WML explained only 0.8% to 11.7% more of the variance in WML progression than age, vascular risk factors, and baseline WML burden. Conclusions— Common genetic factors contribute little to the progression of age-related WML in middle-aged and older adults. Future research on determinants of WML progression should focus more on environmental, lifestyle, or host-related biological factors.

[1]  John Blangero,et al.  MACROD2 gene associated with autistic-like traits in a general population sample , 2014, Psychiatric genetics.

[2]  S. O'Bryant,et al.  Arsenic exposure, AS3MT polymorphism, and neuropsychological functioning among rural dwelling adults and elders: a cross-sectional study , 2014, Environmental Health.

[3]  Cai,et al.  GENOME-WIDE ASSOCIATION STUDY META-ANALYSIS REVEALS TRANS-ETHNIC REPLICATION OF MEAN ARTERIAL AND PULSE PRESSURE LOCI , 2022 .

[4]  S. Ropele,et al.  Incident lacunes preferentially localize to the edge of white matter hyperintensities: insights into the pathophysiology of cerebral small vessel disease. , 2013, Brain : a journal of neurology.

[5]  Simon C. Potter,et al.  Genome-wide Association Analysis Identifies 14 New Risk Loci for Schizophrenia , 2013, Nature Genetics.

[6]  A. Hofman,et al.  The healthy volunteer effect and coronary risk prediction in the general population: the Rotterdam study , 2013 .

[7]  D. Rujescu,et al.  A comprehensive family-based replication study of schizophrenia genes. , 2013, JAMA psychiatry.

[8]  Kaitlin M. Fitzpatrick,et al.  17q25 Locus Is Associated With White Matter Hyperintensity Volume in Ischemic Stroke, But Not With Lacunar Stroke Status , 2013, Stroke.

[9]  K. Kohara,et al.  Association of Chr17q25 with cerebral white matter hyperintensities and cognitive impairment: the J‐SHIPP study , 2013, European journal of neurology.

[10]  M. Daly,et al.  Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis , 2013, The Lancet.

[11]  R. Schmidt,et al.  Genetics of age-related white matter lesions from linkage to genome wide association studies , 2012, Journal of the Neurological Sciences.

[12]  R. Handsaker,et al.  Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder , 2012, Molecular Psychiatry.

[13]  Nicholas R. Lemoine,et al.  SNPnexus: a web server for functional annotation of novel and publicly known genetic variants (2012 update) , 2012, Nucleic Acids Res..

[14]  Christina N. Lessov-Schlaggar,et al.  Longitudinal genetic analysis of brain volumes in normal elderly male twins , 2012, Neurobiology of Aging.

[15]  Benjamin F. J. Verhaaren,et al.  Replication Study of Chr17q25 With Cerebral White Matter Lesion Volume , 2011, Stroke.

[16]  M. Fornage,et al.  Genetic variants of the NOTCH3 gene in the elderly and magnetic resonance imaging correlates of age-related cerebral small vessel disease , 2011, Brain : a journal of neurology.

[17]  Anders D. Børglum,et al.  Genome-wide association study identifies five new schizophrenia loci , 2011, Nature Genetics.

[18]  Christian Gieger,et al.  Genetic Variants in Novel Pathways Influence Blood Pressure and Cardiovascular Disease Risk , 2011, Nature.

[19]  M. Fornage,et al.  Genome‐wide association studies of cerebral white matter lesion burden , 2011, Annals of neurology.

[20]  N. Mehta Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. , 2011, Circulation. Cardiovascular genetics.

[21]  D. Levy,et al.  Discovery and replication of novel blood pressure genetic loci in the Women's Genome Health Study , 2011, Journal of hypertension.

[22]  Boer,et al.  Genome-wide association studies of cerebral white matter lesion burden: the CHARGE Consortium , 2011 .

[23]  Michael Boehnke,et al.  LocusZoom: regional visualization of genome-wide association scan results , 2010, Bioinform..

[24]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[25]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[26]  Alejandro F. Frangi,et al.  Genome-wide association study of intracranial aneurysm identifies three new risk loci , 2010, Nature genetics.

[27]  M. Fornage,et al.  Genome-Wide Association Studies of MRI-Defined Brain Infarcts: Meta-Analysis From the CHARGE Consortium , 2010, Stroke.

[28]  C. Jack,et al.  Blood Pressure and White-Matter Disease Progression in a Biethnic Cohort: Atherosclerosis Risk in Communities (ARIC) Study , 2010, Stroke.

[29]  N. Obuchowski,et al.  Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures , 2010, Epidemiology.

[30]  Vilmundur Gudnason,et al.  Glycemic Status and Brain Injury in Older Individuals , 2009, Diabetes Care.

[31]  Carole Dufouil,et al.  White matter lesions volume and motor performances in the elderly , 2009, Annals of neurology.

[32]  P. O’Reilly,et al.  Genome-wide association study identifies eight loci associated with blood pressure , 2009, Nature Genetics.

[33]  C. Sudlow,et al.  Genetic Determinants of White Matter Hyperintensities on Brain Scans: A Systematic Assessment of 19 Candidate Gene Polymorphisms in 46 Studies in 19 000 Subjects , 2009, Stroke.

[34]  Wiro J. Niessen,et al.  White matter lesion extension to automatic brain tissue segmentation on MRI , 2009, NeuroImage.

[35]  K. Lunetta,et al.  Methods in Genetics and Clinical Interpretation Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Design of Prospective Meta-Analyses of Genome-Wide Association Studies From 5 Cohorts , 2010 .

[36]  Richard Beare,et al.  Cerebral White Matter Lesions, Gait, and the Risk of Incident Falls: A Prospective Population-Based Study , 2009, Stroke.

[37]  Monique M. B. Breteler,et al.  The Rotterdam Study: 2016 objectives and design update , 2015, European Journal of Epidemiology.

[38]  B. Mazoyer,et al.  Longitudinal follow-up of individual white matter hyperintensities in a large cohort of elderly , 2009, Neuroradiology.

[39]  Andrew D. Johnson,et al.  SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap , 2008, Bioinform..

[40]  Wiro J. Niessen,et al.  Brain tissue volumes in the general elderly population The Rotterdam Scan Study , 2008, Neurobiology of Aging.

[41]  P. Macfarlane,et al.  Genetic variation in the interleukin-1 beta-converting enzyme associates with cognitive function. The PROSPER study. , 2008, Brain : a journal of neurology.

[42]  Carole Dufouil,et al.  White Matter Lesions as a Predictor of Depression in the Elderly: The 3C-Dijon Study , 2008, Biological Psychiatry.

[43]  O. Lopez,et al.  Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[44]  A. Hofman,et al.  Incidental findings on brain MRI in the general population. , 2007, The New England journal of medicine.

[45]  Qiong Yang,et al.  The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. , 2007, American journal of epidemiology.

[46]  V. Gudnason,et al.  Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics. , 2007, American journal of epidemiology.

[47]  G. Waldemar,et al.  The apolipoprotein E ɛ4‐allele and antihypertensive treatment are associated with increased risk of cerebral MRI white matter hyperintensities , 2007 .

[48]  K. Lunetta,et al.  Heritability of Magnetic Resonance Imaging (MRI) Traits in Alzheimer Disease Cases and Their Siblings in the MIRAGE Study , 2007, Alzheimer disease and associated disorders.

[49]  A. Hofman,et al.  Polymorphisms of the renin–angiotensin system are associated with blood pressure, atherosclerosis and cerebral white matter pathology , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[50]  G. Waldemar,et al.  The apolipoprotein E epsilon4-allele and antihypertensive treatment are associated with increased risk of cerebral MRI white matter hyperintensities. , 2007, Acta neurologica Scandinavica.

[51]  B. Mazoyer,et al.  An automated procedure for the assessment of white matter hyperintensities by multispectral (T1, T2, PD) MRI and an evaluation of its between-centre reproducibility based on two large community databases , 2007, Neuroradiology.

[52]  Sudha Seshadri,et al.  Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. , 2006, JAMA.

[53]  A. Berghold,et al.  C-Reactive Protein, Carotid Atherosclerosis, and Cerebral Small-Vessel Disease: Results of the Austrian Stroke Prevention Study , 2006, Stroke.

[54]  H. Markus,et al.  Polymorphisms in Genes of the Renin-Angiotensin System and Cerebral Small Vessel Disease , 2006, Cerebrovascular Diseases.

[55]  P. Wolf,et al.  The lifetime risk of stroke: estimates from the Framingham Study. , 2006, Stroke.

[56]  Johan H. C. Reiber,et al.  Fully automatic segmentation of white matter hyperintensities in MR images of the elderly , 2005, NeuroImage.

[57]  D. Harvey,et al.  Measures of brain morphology and infarction in the framingham heart study: establishing what is normal , 2005, Neurobiology of Aging.

[58]  Norman J Beauchamp,et al.  Incidence, Manifestations, and Predictors of Worsening White Matter on Serial Cranial Magnetic Resonance Imaging in the Elderly: The Cardiovascular Health Study , 2005, Stroke.

[59]  N. Pedersen,et al.  Quantitative genetic analysis of latent growth curve models of cognitive abilities in adulthood. , 2005, Developmental psychology.

[60]  Charles DeCarli,et al.  Stroke Risk Profile Predicts White Matter Hyperintensity Volume: The Framingham Study , 2004, Stroke.

[61]  Charles DeCarli,et al.  Genetic Variation in White Matter Hyperintensity Volume in the Framingham Study , 2004, Stroke.

[62]  Jan Cees de Groot,et al.  Interaction Between Hypertension, apoE, and Cerebral White Matter Lesions , 2004, Stroke.

[63]  M. Fornage,et al.  Heritability of Leukoaraiosis in Hypertensive Sibships , 2004, Hypertension.

[64]  A. Hofman,et al.  Determinants of disease and disability in the elderly: The Rotterdam elderly study , 1991, European Journal of Epidemiology.

[65]  Hugh S Markus,et al.  Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. , 2004, Brain : a journal of neurology.

[66]  R. Holman,et al.  Vascular Factors and Risk of Dementia: Design of the Three-City Study and Baseline Characteristics of the Study Population , 2003, Neuroepidemiology.

[67]  K. Kohara,et al.  MTHFR Gene Polymorphism as a Risk Factor for Silent Brain Infarcts and White Matter Lesions in the Japanese General Population: The NILS-LSA Study , 2003, Stroke.

[68]  A. Hofman,et al.  Silent Brain Infarcts and White Matter Lesions Increase Stroke Risk in the General Population: The Rotterdam Scan Study , 2003, Stroke.

[69]  A. Hofman,et al.  Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam Study , 2003, Journal of neurology, neurosurgery, and psychiatry.

[70]  Oscar L. Lopez,et al.  Evaluation of Dementia in the Cardiovascular Health Cognition Study , 2003, Neuroepidemiology.

[71]  P. Macfarlane,et al.  Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial , 2002, The Lancet.

[72]  Alan C. Evans,et al.  Automatic "pipeline" analysis of 3-D MRI data for clinical trials: application to multiple sclerosis , 2002, IEEE Transactions on Medical Imaging.

[73]  K. Christensen,et al.  The Heritability of Level and Rate-of-Change in Cognitive Functioning in Danish Twins Aged 70 Years and Older , 2002, Experimental aging research.

[74]  M. Soleimani Na+:HCO3- cotransporters (NBC): expression and regulation in the kidney. , 2002, Journal of nephrology.

[75]  J. Bamford,et al.  Angiotensin converting enzyme insertion/deletion genotype is associated with leukoaraiosis in lacunar syndromes , 2002, Journal of neurology, neurosurgery, and psychiatry.

[76]  A. de la Sierra,et al.  Renin-Angiotensin System Genetic Polymorphisms and Cerebral White Matter Lesions in Essential Hypertension , 2002, Hypertension.

[77]  F. Fazekas,et al.  Angiotensinogen Polymorphism M235T, Carotid Atherosclerosis, and Small-Vessel Disease-Related Cerebral Abnormalities , 2001, Hypertension.

[78]  C. Furberg,et al.  Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study , 2001, Neurology.

[79]  P. Macfarlane,et al.  The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk. , 1999, The American journal of cardiology.

[80]  F. Fazekas,et al.  MRI white matter hyperintensities , 1999, Neurology.

[81]  A. Folsom,et al.  Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. , 1999, Stroke.

[82]  L. Wahlund,et al.  White Matter Lesions in Alzheimer Patients Are Influenced by Apolipoprotein E Genotype , 1999, Dementia and Geriatric Cognitive Disorders.

[83]  M. Soleimani,et al.  Characterization of Na+/HCO-3 cotransporter isoform NBC-3. , 1999, The American journal of physiology.

[84]  G. Wilcock,et al.  Are genetic factors important in the aetiology of leukoaraiosis? Results from a memory clinic population , 1998, International journal of geriatric psychiatry.

[85]  B L Miller,et al.  Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. , 1998, Stroke.

[86]  M. Kraut,et al.  Cigarette smoking and other risk factors for silent cerebral infarction in the general population. , 1998, Stroke.

[87]  L. Almasy,et al.  Multipoint quantitative-trait linkage analysis in general pedigrees. , 1998, American journal of human genetics.

[88]  A. Hoes,et al.  Prevalence of stroke in the general population. The Rotterdam Study. , 1996, Stroke.

[89]  Teri,et al.  A method for using MR to evaluate the effects of cardiovascular disease on the brain: the cardiovascular health study. , 1994, AJNR. American journal of neuroradiology.

[90]  F. Fazekas,et al.  Assessment of cerebrovascular risk profiles in healthy persons: definition of research goals and the Austrian Stroke Prevention Study (ASPS). , 1994, Neuroepidemiology.

[91]  B. Horwitz,et al.  Method for quantification of brain, ventricular, and subarachnoid CSF volumes from MR images. , 1992, Journal of computer assisted tomography.

[92]  N. Nagelkerke,et al.  A note on a general definition of the coefficient of determination , 1991 .

[93]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[94]  P. Allhoff,et al.  The Framingham Offspring Study , 1991 .

[95]  Aric Invest The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators , 1989 .

[96]  A. Folsom,et al.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.

[97]  H Lechner,et al.  White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. , 1988, Stroke.

[98]  R F Spetzler,et al.  Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors. , 1986, Stroke.

[99]  W. Kannel,et al.  The Framingham Offspring Study. Design and preliminary data. , 1975, Preventive medicine.

[100]  W. Kannel,et al.  The Framingham Study An Epidemiological Approach to Coronary Heart Disease , 1966, Circulation.